Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, posted the following on X:
“My goodness – this Cell Metabolism cover!
Athena, wielding a shield empowered by the serine-glycine free diet, makes the tumor eye (MHC-I) more prominent for CD8+ T cells, while her owl (PD-1 inhibitor) targets PD-L1 to weaken tumor defenses, symbolizing synergistic therapy.”
